Exhibit 99.1
Everyday Health Reports Record Full Year and Fourth Quarter 2015 Financial Results
NEW YORK – March 1, 2016 – Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health marketing and communications solutions, today announced financial results for the fourth quarter and full year ended December 31, 2015.
For the full year 2015:
| · | Total revenue grew 26% year-over-year. |
| · | Revenue from the top 30 strategic advertisers increased 30% year-over-year. |
| · | Pharma revenue grew 30% year-over-year. |
| · | Adjusted EBITDA increased 27% year-over-year. |
For the fourth quarter:
| · | Total revenue grew 30% year-over-year. |
| · | Revenue from the top 30 strategic advertisers increased 42% year-over-year. |
| · | Pharma revenue grew 28% year-over-year. |
| · | Adjusted EBITDA increased 39% year-over-year. |
“In 2015, we made great strides in building the leading marketing platform for the healthcare sector,” said Ben Wolin, Co-Founder and CEO of Everyday Health. “We dramatically expanded our market opportunity, diversified our customer base and invested in our sales capabilities to better serve our customers. We now provide innovative solutions to pharma companies, CPG marketers, hospital systems and health insurers, and we can help all of these customers achieve their most important strategic objectives.”
Financial Highlights
For the twelve months ended December 31, 2015:
| · | Total revenue was $232.0 million, a 26% increase from the prior year period. |
| o | Advertising and sponsorship revenue was $209.1 million, a 26% increase from the prior year period. |
| o | Premium services revenue, which now includes SaaS fees from hospital systems, was $22.9 million, a 28% increase from the prior year period. | |
| · | Adjusted EBITDA was $45.6 million, a 27% increase from the prior year period. | |
| · | Net income on a non-GAAP basis was $20.0 million, compared to non-GAAP net income of $17.4 million in the prior year period. Earnings per share on a non-GAAP basic and diluted basis was $0.63 and $0.60, compared to $0.72 and $0.65, respectively, in 2014. A description of the non-GAAP calculations and reconciliation to comparable GAAP measures is provided in the accompanying tables entitled “Adjusted EBITDA Reconciliation” and “Reconciliation of Non-GAAP Net Income.” |
| · | Net loss on a GAAP basis was $(11.6) million, compared to net income of $12.7 million in the prior year period before the impact of the non-cash, one-time deemed dividend of $8.1 million associated with the conversion of the Company's Series G preferred stock at the time of its initial public offering. Loss per share on a GAAP basic and diluted basis was $(0.36), compared to earnings per share of $0.52 and $0.47, respectively, in 2014 before the Series G deemed dividend. | |
| · | Cash flow from operations was $20.9 million, up from $20.0 million in 2014. |
For the three months ended December 31, 2015:
| · | Total revenue was $81.7 million, a 30% increase from the prior year period. | |
| o | Advertising and sponsorship revenue was $72.9 million, a 24% increase from the prior year period. | |
| o | Premium services revenue, including SaaS fees, was $8.8 million, a 116% increase from the prior year period. | |
| · | Adjusted EBITDA was $26.1 million, a 39% increase from the prior year period. | |
| · | Net income on a non-GAAP basis was $19.5 million, compared to non-GAAP net income of $13.9 million in the prior year period. Earnings per share on a non-GAAP basic and diluted basis was $0.60 and $0.59, respectively, compared to $0.45 and $0.42, respectively, in the fourth quarter of 2014. A description of the non-GAAP calculations and reconciliation to comparable GAAP measures is provided in the accompanying tables entitled “Adjusted EBITDA Reconciliation” and “Reconciliation of Non-GAAP Net Income.” | |
| · | Net income on a GAAP basis was $7.5 million, compared to net income of $21.2 million in the prior year period. Earnings per share on both a GAAP basic and diluted basis was $0.23, compared to $0.68 and $0.64, respectively, in the fourth quarter of 2014. |
“We delivered record results in 2015, with total revenue and Adjusted EBITDA each growing in excess of 25% over 2014,” said Brian Cooper, CFO of Everyday Health. “The strategic investments we have made will drive further growth in 2016, and we remain confident in our ability to achieve our long term growth and profitability targets.”
Financial Outlook
For the first quarter of 2016 and the full year 2016, the Company anticipates achieving financial results as set forth below:
| First Quarter of 2016 | ||
| Total Revenue | $47.0 million – $51.0 million | |
| Advertising & Sponsorship Revenue | $43.0 million – $47.0 million | |
| Adjusted EBITDA | $(0.5) million – $0.5 million | |
| Full Year 2016 | ||
| Total Revenue | $250.0 million – $260.0 million | |
| Advertising & Sponsorship Revenue | $233.0 million – $243.0 million | |
| Adjusted EBITDA | $43.6 million – $47.6 million | |
Earnings Teleconference Information
The Company will discuss its fourth quarter and full year 2015 financial results and business outlook during a teleconference today, March 1, 2016, at 4:30 PM ET. The conference call can be accessed at (877) 201-0168 or (647) 788-4901 (International), conference ID# 49703128 or via live webcast at http://ir.everydayhealth.com.
Following completion of the call, a recorded replay of the webcast will be available on Everyday Health’s website. To listen to the telephone replay, call toll-free (855) 859-2056 or (404) 537-3406 (International), conference ID# 49703128. The telephone replay will be available from 7:30 PM ET March 1, 2016 through 11:59 PM ET March 8, 2016. Additional investor information can be accessed at http://ir.everydayhealth.com.
About Everyday Health, Inc.
Everyday Health, Inc. (NYSE: EVDY) is a leading provider of digital health marketing and communications solutions. Everyday Health attracts a large and engaged audience of consumers and healthcare professionals to its premier health and wellness properties, and utilizes its data and analytics expertise to deliver highly personalized content experiences and efficient and effective marketing and engagement solutions. Everyday Health enables consumers to manage their daily health and wellness needs, healthcare professionals to stay informed and make better decisions for their patients, and marketers, health payers and providers to communicate and engage with consumers and healthcare professionals to drive better health outcomes. Everyday Health's content and solutions are delivered through multiple channels, including desktop, mobile web, and mobile phone and tablet applications, as well as video and social media.
Safe Harbor Provision
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by their use of terms and phrases such as “anticipate,” “enable,” “expect,” “will,” “believe,” “continue” and other similar terms and phrases, and such forward-looking statements include, but are not limited to, the statements regarding our future financial performance set forth under the heading “Financial Outlook.” The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: our ability to attract and retain users to our properties; our ability to attract and retain customers; the timing and amount of advertising spending by our current and future customers; our ability to effectively integrate the acquisitions that we make; our ability to enter into new, or extend existing, partnership arrangements; our ability to successfully pursue opportunities in the broader health and wellness sectors; as well as those factors contained in the “Risk Factors” section of our SEC filings. All information in this release is as of March 1, 2016. Except as required by law, we undertake no obligation to update publicly any forward-looking statement made herein for any reason to conform the statement to actual results or changes in our expectations.
Use of Non-GAAP Financial Measures
To supplement the financial measures presented in the Company’s press release and related conference call or webcast in accordance with accounting principles generally accepted in the United States ("GAAP"), we also present the following non-GAAP measures of financial performance: Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per share ("EPS").
A "non-GAAP financial measure" refers to a numerical measure of the Company’s historical or future financial performance, financial position, or cash flows that excludes (or includes) amounts that are included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s financial statements. The Company provides certain non-GAAP measures as additional information relating to its operating results as a complement to results provided in accordance with GAAP. The non-GAAP financial information presented here should be considered in conjunction with, and not as a substitute for or superior to, the financial information presented in accordance with GAAP and should not be considered a measure of the Company’s liquidity. There are significant limitations associated with the use of non-GAAP financial measures. Further, these measures may differ from the non-GAAP information, even where similarly titled, used by other companies and therefore should not be used to compare the Company’s performance to that of other companies.
The Company has presented Adjusted EBITDA, non-GAAP net income and non-GAAP EPS as non-GAAP financial measures in this press release. We define Adjusted EBITDA as net income (loss) plus: interest expense, net; income tax provision (benefit); depreciation and amortization expense; stock-based compensation expense; compensation expense related to acquisition earnout and retention bonus arrangements; write-offs of unamortized deferred financing and other debt extinguishment costs; executive transition and reduction in force charges; contract settlement charges; asset impairment and other charges; and preferred stock warrant mark-to-market adjustments. We define non-GAAP net income as net income (loss), plus non-cash stock-based compensation expense, compensation expense related to acquisition earnout and retention bonus arrangements, income tax provision (benefit), and other unusual or significant adjustments such as the write-off of deferred financing costs and other debt extinguishment costs, executive transition and reduction in force charges, contract settlement charges, asset impairment and other charges, and the preferred stock warrant mark-to-market adjustment. We define non-GAAP EPS as non-GAAP net income, divided by weighted-average shares outstanding, which reflects the issuance of the shares sold in the Company’s IPO, which closed on April 2, 2014, as well as the conversion of all outstanding shares of preferred stock into common stock in connection with the IPO.
The Company believes the use of non-GAAP financial measures, as a supplement to GAAP measures, is useful to investors in that they eliminate items that are either not part of the Company’s core operations or do not require a cash outlay, such as stock-based compensation. Our management uses these non-GAAP financial measures when evaluating the Company’s operating performance and for internal planning and forecasting purposes. The Company believes that these non-GAAP financial measures help indicate underlying trends in the Company’s business, are important in comparing current results with prior period results, and are useful to investors and financial analysts in assessing the Company’s operating performance.
Source: Everyday Health
Investor Relations Contact:
Melanie Goldey, SVP, Strategic Planning & IR
(646) 728-9768
ir@everydayhealthinc.com
EVERYDAY HEALTH, INC.
Consolidated Balance Sheets
(in thousands, except share and per share data)
| December 31, | ||||||||
| 2015 (unaudited) | 2014 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 30,097 | $ | 50,729 | ||||
| Accounts receivable, net of allowance for doubtful accounts of $909 and $637 as of December 31, 2015 and 2014, respectively | 90,356 | 68,007 | ||||||
| Prepaid expenses and other current assets | 4,662 | 5,529 | ||||||
| Total current assets | 125,115 | 124,265 | ||||||
| Property and equipment, net | 28,565 | 25,502 | ||||||
| Goodwill | 165,271 | 127,115 | ||||||
| Intangible assets, net | 43,746 | 30,716 | ||||||
| Other assets | 6,901 | 5,237 | ||||||
| Total assets | $ | 369,598 | $ | 312,835 | ||||
| Liabilities and stockholders’ equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | 38,563 | $ | 31,722 | ||||
| Deferred revenue | 8,655 | 6,740 | ||||||
| Current portion of long-term debt | 6,775 | 3,000 | ||||||
| Other current liabilities | 11,890 | 965 | ||||||
| Total current liabilities | 65,883 | 42,427 | ||||||
| Long-term debt | 104,281 | 87,000 | ||||||
| Deferred tax liabilities | 7,570 | 6,017 | ||||||
| Other long-term liabilities | 11,595 | 4,105 | ||||||
| Stockholders’ equity: | ||||||||
| Preferred stock, $0.01 par value: 10,000,000 shares authorized at December 31, 2015 and 2014; no shares issued and outstanding at December 31, 2015 and 2014 | - | - | ||||||
| Common stock, $0.01 par value: 90,000,000 shares authorized at December 31, 2015 and 2014; 32,707,606 and 31,489,196 shares issued and outstanding at December 31, 2015 and 2014, respectively | 327 | 314 | ||||||
| Treasury stock | (55 | ) | (55 | ) | ||||
| Additional paid-in capital | 310,727 | 292,117 | ||||||
| Accumulated deficit | (130,730 | ) | (119,090 | ) | ||||
| Total stockholders’ equity | 180,269 | 173,286 | ||||||
| Total liabilities and stockholders’ equity | $ | 369,598 | $ | 312,835 | ||||
EVERYDAY HEALTH, INC.
Consolidated Statements of Operations
(in thousands, except share and per share data, unaudited)
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Revenues: | ||||||||||||||||
| Advertising and sponsorship revenues | $ | 72,900 | $ | 58,981 | $ | 209,093 | $ | 166,465 | ||||||||
| Premium services revenues | 8,798 | 4,068 | 22,898 | 17,860 | ||||||||||||
| Total revenues | 81,698 | 63,049 | 231,991 | 184,325 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Cost of revenues | 23,284 | 15,908 | 66,923 | 49,296 | ||||||||||||
| Sales and marketing | 22,464 | 13,956 | 74,761 | 48,605 | ||||||||||||
| Product development | 16,968 | 12,088 | 55,920 | 44,541 | ||||||||||||
| General and administrative | 9,608 | 8,816 | 39,487 | 30,041 | ||||||||||||
| Total operating expenses | 72,324 | 50,768 | 237,091 | 172,483 | ||||||||||||
| Income (loss) from operations | 9,374 | 12,281 | (5,100 | ) | 11,842 | |||||||||||
| Interest expense, net | (1,428 | ) | (763 | ) | (5,236 | ) | (3,711 | ) | ||||||||
| Other expense | - | - | - | (4,114 | ) | |||||||||||
| Income (loss) from operations before (provision) benefit for income taxes | 7,946 | 11,518 | (10,336 | ) | 4,017 | |||||||||||
| (Provision) benefit for income taxes | (494 | ) | 9,669 | (1,304 | ) | 8,666 | ||||||||||
| Net income (loss) | 7,452 | 21,187 | (11,640 | ) | 12,683 | |||||||||||
| Series G preferred stock deemed dividend | - | - | - | (8,079 | ) | |||||||||||
| Net income (loss) attributable to common stockholders | $ | 7,452 | $ | 21,187 | $ | (11,640 | ) | $ | 4,604 | |||||||
| Net income (loss) attributable to common stockholders per common share: | ||||||||||||||||
| Basic | $ | 0.23 | $ | 0.68 | $ | (0.36 | ) | $ | 0.19 | |||||||
| Diluted | $ | 0.23 | $ | 0.64 | $ | (0.36 | ) | $ | 0.17 | |||||||
| Weighted-average common shares outstanding: | ||||||||||||||||
| Basic | 32,482,159 | 31,076,588 | 31,977,246 | 24,259,395 | ||||||||||||
| Diluted | 32,904,143 | 32,977,544 | 31,977,246 | 26,911,782 | ||||||||||||
EVERYDAY HEALTH, INC.
Consolidated Statements of Cash Flows
(in thousands)
| Twelve months ended December 31, | ||||||||
| 2015 (unaudited) | 2014 | |||||||
| Cash flows from operating activities | ||||||||
| Net income (loss) | $ | (11,640 | ) | $ | 12,683 | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 20,408 | 14,943 | ||||||
| Provision for doubtful accounts | 326 | 315 | ||||||
| Stock-based compensation | 10,936 | 9,100 | ||||||
| Amortization and write-off of financing costs | 540 | 4,389 | ||||||
| Asset impairment charge | 1,416 | - | ||||||
| (Benefit) provision for deferred income taxes | 952 | (9,071 | ) | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (17,490 | ) | (12,437 | ) | ||||
| Prepaid expenses and other current assets | 982 | 1,489 | ||||||
| Accounts payable and accrued expenses | 5,420 | (1,942 | ) | |||||
| Deferred revenue | 1,183 | (68 | ) | |||||
| Other current liabilities | 154 | 58 | ||||||
| Other long-term liabilities | 7,759 | 581 | ||||||
| Net cash provided by operating activities | 20,946 | 20,040 | ||||||
| Cash flows from investing activities | ||||||||
| Additions to property and equipment, net | (14,481 | ) | (14,754 | ) | ||||
| Proceeds from sale of business | - | 400 | ||||||
| Payment for businesses purchased, net of cash acquired | (47,316 | ) | (65,000 | ) | ||||
| Payment of security deposits and other assets | (1,413 | ) | 131 | |||||
| Net cash used in investing activities | (63,210 | ) | (79,223 | ) | ||||
| Cash flows from financing activities | ||||||||
| Net proceeds from common stock issuance | - | 70,622 | ||||||
| Proceeds from the exercise of stock options | 2,633 | 7,939 | ||||||
| Repayments of principal under former revolver credit facility | - | (30,000 | ) | |||||
| Repayment of principal under former term loan facility | - | (41,333 | ) | |||||
| Borrowings under revolver credit facility | 25,000 | 62,300 | ||||||
| Repayment of principal under revolver credit facility | (10,000 | ) | (32,300 | ) | ||||
| Borrowings under term loan facility | 8,500 | 61,000 | ||||||
| Repayment of principal under term loan facility | (2,444 | ) | (1,000 | ) | ||||
| Principal payments on capital lease obligations | (642 | ) | (659 | ) | ||||
| Tax withholdings related to net share settlements of restricted stock units | (623 | ) | - | |||||
| Payments of credit facility financing costs | (792 | ) | (2,899 | ) | ||||
| Net cash provided by financing activities | 21,632 | 93,670 | ||||||
| Net increase (decrease) in cash and cash equivalents | (20,632 | ) | 34,487 | |||||
| Cash and cash equivalents, beginning of period | 50,729 | 16,242 | ||||||
| Cash and cash equivalents, end of period | $ | 30,097 | $ | 50,729 | ||||
EVERYDAY HEALTH, INC.
Adjusted EBITDA Reconciliation
(in thousands, unaudited)
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Adjusted EBITDA | $ | 26,132 | $ | 18,747 | $ | 45,644 | $ | 36,019 | ||||||||
| Less: | ||||||||||||||||
| Interest expense, net | 1,428 | 763 | 5,236 | 3,711 | ||||||||||||
| Income tax provision (benefit) | 494 | (9,669 | ) | 1,304 | (8,666 | ) | ||||||||||
| Depreciation and amortization expense | 5,251 | 4,114 | 20,408 | 14,943 | ||||||||||||
| Stock-based compensation expense | 2,720 | 2,352 | 10,936 | 9,100 | ||||||||||||
| Warrant mark-to-market adjustment | - | - | - | 252 | ||||||||||||
| Compensation expense related to acquisition earnout and retention bonuses | 7,382 | - | 11,968 | 135 | ||||||||||||
| Write-off of unamortized deferred financing costs | - | - | - | 3,861 | ||||||||||||
| Executive transition and reduction in force severance charges | 769 | - | 3,655 | - | ||||||||||||
| Contract settlement charge | - | - | 1,725 | - | ||||||||||||
| Asset impairment and other charges | 636 | - | 2,052 | - | ||||||||||||
| Net Income (loss) | $ | 7,452 | $ | 21,187 | $ | (11,640 | ) | $ | 12,683 | |||||||
EVERYDAY HEALTH, INC.
Reconciliation of Non-GAAP Net Income
(in thousands, except share and per share data, unaudited)
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Net Income (loss) | $ | 7,452 | $ | 21,187 | $ | (11,640 | ) | $ | 12,683 | |||||||
| Stock-based compensation expense | 2,720 | 2,352 | 10,936 | 9,100 | ||||||||||||
| Income tax provision (benefit) | 494 | (9,669 | ) | 1,304 | (8,666 | ) | ||||||||||
| Warrant mark-to-market adjustment | - | - | - | 252 | ||||||||||||
| Compensation expense related to acquisition earnout and retention bonuses | 7,382 | - | 11,968 | 135 | ||||||||||||
| Write-off of unamortized deferred financing costs | - | - | - | 3,861 | ||||||||||||
| Executive transition and reduction in force severance charges | 769 | - | 3,655 | - | ||||||||||||
| Contract settlement charge | - | - | 1,725 | - | ||||||||||||
| Asset impairment and other charges | 636 | - | 2,052 | - | ||||||||||||
| Non-GAAP net income | $ | 19,453 | $ | 13,870 | $ | 20,000 | $ | 17,365 | ||||||||
| Weighted-average common shares outstanding-basic | 32,482,159 | 31,076,588 | 31,977,246 | 24,259,395 | ||||||||||||
| Weighted-average common shares outstanding-diluted | 32,904,143 | 32,977,544 | 33,313,328 | 26,911,782 | ||||||||||||
| Non-GAAP net income per common share-basic | $ | 0.60 | $ | 0.45 | $ | 0.63 | $ | 0.72 | ||||||||
| Non-GAAP net income per common share-diluted | $ | 0.59 | $ | 0.42 | $ | 0.60 | $ | 0.65 | ||||||||